Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | HDFC Business Cycle Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Nippon India | HDFC |
| NAV | ₹591.2429 | ₹15.6450 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 20.6 years | 4.0 years |
| Expense ratio | 1.8% | 2.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 78.10 | 49.20 |
Returns
| Nippon India Pharma Fund | HDFC Business Cycle Fund | |
|---|---|---|
| 1 month | +11.32% | +7.59% |
| 3 months | +3.52% | +1.66% |
| 6 months | +8.09% | +11.28% |
| YTD | +16.05% | +6.77% |
| 1 year | +14.27% | +4.91% |
| 3 years (CAGR) | +16.91% | +10.77% |
| 5 years (CAGR) | +14.37% | — |
| 10 years (CAGR) | +15.58% | — |
| Since launch | +17.64% | +11.89% |
Risk
| Nippon India Pharma Fund | HDFC Business Cycle Fund | |
|---|---|---|
| Volatility | 14.1% | 15.5% |
| Downside volatility | 9.1% | 10.5% |
| Sharpe | 0.74 | 0.28 |
| Sortino | 1.15 | 0.41 |
| Calmar | 1.14 | 0.56 |
| Return / risk | 1.20 | 0.70 |
| Deepest fall | −47.36% | −19.40% |
| Days to recover | 301 | 234 |
| Below its high | +0.00% | +0.00% |
Against benchmark
| Nippon India Pharma Fund | HDFC Business Cycle Fund | |
|---|---|---|
| Alpha | −2.75% | −0.70% |
| Beta | 0.89 | 0.92 |
| R² | 89.5% | 90.6% |
| Up capture | 83.5% | 92.4% |
| Down capture | 91.2% | 94.3% |
| Tracking error | 4.8% | 4.9% |
| Information ratio | −0.88 | −0.23 |
| Treynor | 0.11 | 0.04 |
Consistency
| Nippon India Pharma Fund | HDFC Business Cycle Fund | |
|---|---|---|
| Best 1-year | +175.79% | +38.26% |
| Middle 1-year | +13.84% | +5.55% |
| Worst 1-year | −36.67% | −7.13% |
| 1-year periods with a loss | 23.4% | 14.6% |
| Middle 3-year | +20.93% | +11.45% |
| Positive months | 63.9% | 61.1% |
| Best day | +3.40% | +4.11% |
| Worst day | −3.21% | −6.25% |
| Worst 5% day | −1.38% | −1.53% |
| Positive days | 53.7% | 54.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | HDFC Business Cycle Fund | |
|---|---|---|
| 5-year XIRR | +17.18% | — |
| 5-year value | ₹9,29,284 | — |
| 3-year XIRR | +13.26% | +7.42% |
| 1-year XIRR | +21.05% | +13.95% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.